A Study on the Efficacy and User Experience of Gamified Intervention for Children With Anisometropic Amblyopia
An Exploratory Study on the Short-Term Additive Efficacy and User Experience of Innovative Gamified Intervention as an Adjunctive Therapy for Children With Monocular Anisometropic Amblyopia
2 other identifiers
interventional
66
1 country
1
Brief Summary
This project addresses the challenge of visual function intervention in children with monocular anisometropic amblyopia. It employs two innovatively designed digital games combined with occlusion therapy to conduct visual function training through parent-child interaction in home or multi-scenario environments. The study will compare this combined approach against traditional occlusion therapy alone, evaluating improvements in visual function, intrinsic motivation, and emotion regulation before and after the intervention. The research aims to promote the implementation and dissemination of personalized and engaging healthcare services. Ultimately, it seeks to establish a comprehensive visual function training product and service system suitable for daily use in home settings, with the goals of reducing medical anxiety in children and holistically enhancing treatment efficacy, training compliance, and overall clinical experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2025
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
July 30, 2026
April 1, 2026
7 months
December 4, 2025
July 29, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Number of participants with Objective improvement in visual function
Contrast sensitivity measured using the standard contrast sensitivity test;Stereopsis measured using the Titmus Fly Test;Simultaneous perception assessed using the Worth 4-dot test;Fusion ability assessed using the synoptophore with line fusion targets.
3 months after the first visit
Best-Corrected Visual Acuity (BCVA) assessed by LogMAR chart
3 months after the first visit
Secondary Outcomes (5)
Improvement in functional vision in daily living
3 months after the first visit
Medical fear assessed by Child Medical Fear Scale (CMFS)
3 months after the first visit
Anxiety assessed by Child Anxiety Meter-State (CAM-S)
3 months after the first visit
Compliance
3 months after the first visit
Acceptance
3 months after the first visit
Study Arms (3)
Group 1 (Intervention)
EXPERIMENTALSerious touchscreen game combined with occlusion
Group 2 (Intervention)
EXPERIMENTALAugmented Reality game combined with occlusion
Control Group
ACTIVE COMPARATOROcclusion therapy only
Interventions
The game designed for amblyopia training feature innovative designs.
The game designed for amblyopia training feature innovative designs.
Eligibility Criteria
You may qualify if:
- Clinically diagnosed with monocular anisometropic amblyopia.
- Aged 4 to 7 years.
- Able to cooperate with all examinations and comply with the amblyopia training regimen.
- Provided signed informed consent.
You may not qualify if:
- Severe developmental delay or cognitive impairment.
- Serious systemic diseases.
- Presence of organic ocular diseases (e.g., cataract, fundus diseases) or manifest strabismus.
- Participation in any other eye-related interventional trial within the past 4 weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200092, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician of the Department of Ophthalmology
Study Record Dates
First Submitted
December 4, 2025
First Posted
March 16, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Due to participant privacy considerations and the terms of the ethical approval and informed consent documents for this study, individual participant data will not be publicly shared. Aggregated data and study results will be disseminated through academic publications.